Dae Y. Lee, Esq., Pharm.D is a pharmacist attorney in Frier Levitt’s Life Sciences Department. Dae’s practice focuses on pharmacy operations, PBM regulation, and pharmaceutical/medical device product liability litigation. He has represented the interests of clients in various product liability cases, including, but not limited to Actos, Incretin-based and other diabetes medications, GranfuFlo/NaturaLyte dialysate, Da Vinci surgical devices, power morcellators, and testosterone replacement therapy.
Prior to joining Frier Levitt, Dae handled litigation involving the prescription drugs Risperdal and AndroGel, in which he represented the interests of bellwether trial plaintiffs and frequently made court appearances for oral arguments. He has also represented clients injured by fluoroquinolone antibiotics, transvaginal mesh implants, SGLT-2 diabetes medications, and forced air warming devices used during surgical procedures.
In additional to his legal background, Dae has experience, as part of the Ernest Mario School of Pharmacy program, in retail pharmacies, hospitals, and an investment bank where he contributed to advising investors about biopharmaceuticals.
Dae is fluent in Korean.
Maurice A. Deane School of Law at Hofstra University
Rutgers University, Ernest Mario School of Pharmacy
- State of New York
- State of New Jersey
- American Association for Justice
- Super Lawyers – New York Metro Rising Stars (2018)
- National Trial Lawyers to New York’s Top 40 Under 40 Civil Plaintiff’s Attorneys (2017)